Syndecan-4 as a Marker of Endothelial Dysfunction in Patients with Resistant Hypertension

(1) Background: Arterial hypertension (HTN) is one of the most relevant cardiovascular risk factors. Nowadays multiple pharmaceutical treatment options exist with novel interventional methods (e.g., baroreflex activation therapy (BAT)) as a last resort to treat patients with resistant HTN. Although...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Med
Main Authors: Lipphardt, Mark, Dihazi, Hassan, Maas, Jens-Holger, Schäfer, Ann-Kathrin, Amlaz, Saskia I., Ratliff, Brian B., Koziolek, Michael J., Wallbach, Manuel
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7564403/
https://ncbi.nlm.nih.gov/pubmed/32971813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9093051
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados